enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir

   Sofosbuvir is also used with other medications and longer treatment durations, depending on specific circumstances, genotype and cost-effectiveness–based perspective. For example, for the treatment of genotypes 1, 4, 5, and 6 hepatitis C infections, sofosbuvir can be used in combination with the viral NS5A inhibitor ledipasvir. [16]

3. Elbasvir/grazoprevir - Wikipedia

   en.wikipedia.org/wiki/Elbasvir/grazoprevir

   Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and ...

4. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   Treatment of people aged twelve years of age and older with solid tumors that: have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and have progressed following treatment or have no satisfactory alternative therapy [2]

5. Here's What Hepatitis C Actually Is—and How You Get It - AOL

   www.aol.com/lifestyle/heres-hepatitis-c-actually...

   In fact, the rate of new hepatitis C cases more than quadrupled over the last decade, according to a study conducted by the Centers for Disease Control and Prevention (CDC). Dr. Dr.

6. Sofosbuvir/velpatasvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

   Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]

7. New Hep C Data Impressive, but It's Not There Yet - AOL

   www.aol.com/news/2012-01-19-new-hep-c-data...

   Bristol-Myers Squibb's (NYS: BMY) latest data on its current hepatitis C drugs explain why the pharma needed to purchase Inihibitex (NAS: INHX) . A combination of its drugs -- daclatasvir and ...

8. Ledipasvir/sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Ledipasvir/sofosbuvir

   Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. [8] It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9]

9. Gilead Anti-Hep-C Treatment on the FDA Fast Track - AOL

   www.aol.com/news/2013-06-08-gilead-anti-hep-c...

   Sofosbuvir is a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus. Gilead Sciences has received FDA priority review status for its New Drug Application ...